Loading
A phase 3 trial of Filgrastim, Amsacrine, Cyclophosphamide, Cytarabine, Daunorubicin, Etoposide, Idarubicin, Mitoxantrone, Thioguanine and Tretinoin in Leukaemia, run by Medical Research Council, with a status the registry has not verified recently.
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT00002658 by Medical Research Council, with 2000 participants planned, started 1994-01. Interventions recorded: filgrastim, amsacrine, cyclophosphamide, cytarabine, daunorubicin hydrochloride, etoposide, idarubicin, mitoxantrone hydrochloride, thioguanine, tretinoin, allogeneic bone marrow transplantation, autologous bone marrow transplantation, peripheral blood stem cell transplantation, radiation therapy. Conditions recorded: Leukemia, Neutropenia.
Linked to the drug Amsacrine because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Shares Amsacrine, Idarubicin, Mitoxantrone, Filgrastim (G-CSF) and the tag pipeline.
Shares Amsacrine, MRC Clinical Trials Unit at UCL, Mitoxantrone, Daunorubicin and the tag pipeline.
Shares Thioguanine, Mitoxantrone, Daunorubicin, Cytarabine and the tag pipeline.
Shares Mitoxantrone, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
Shares Thioguanine, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
Shares Idarubicin, Mitoxantrone, Daunorubicin, Cytarabine and the tag pipeline.
Shares Daunorubicin, Filgrastim (G-CSF), Cytarabine, Etoposide and the tag pipeline.
Shares Thioguanine, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.